Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Reiterates Overweight Rating on 89bio Inc. (ETNB)
-
Cantor Fitzgerald Reiterates Overweight Rating on Archer Aviation Inc. (ACHR)
-
Bitfarms Provides February 2025 Production and Operations Update
-
MoneyShow Investment Masters Symposium to feature Craig O'Sullivan as guest speaker along with Jim Bianco, Dan Ives, Tom Lee, Kathryn Vera, and Ed Yardeni
-
How Kamada (NASDAQ: KMDA) Is Transforming Its Strategic Focus Into Commercial Growth
-
Nlight (LASR) PT Lowered to $14 at Cantor Fitzgerald
-
Progyny (PGNY) PT Raised to $26 at Cantor Fitzgerald
-
Nerdy (NRDY) PT Raised to $1.50 at Cantor Fitzgerald
-
DocGo (DCGO) PT Lowered to $4 at Cantor Fitzgerald
-
CrowdStrike Holdings (CRWD) PT Raised to $440 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Avidity Biosciences (RNA)
-
Cantor Fitzgerald Reiterates Overweight Rating on PureCycle Technolgies (PCT)
-
Crinetics (CRNX) PT Raised to $100 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on 89bio Inc. (ETNB)
-
Rocket Pharmaceuticals (RCKT) PT Lowered to $50 at Cantor Fitzgerald
-
Oranogenesis Holdings (ORGO) PT Raised to $6 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Janux Therapeutics (JANX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Rocket Lab USA (RKLB)
-
Fifth Era Acquisition Corp I Announces the Pricing of $200,000,000 Initial Public Offering
-
Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates
-
Cipher Mining Announces Participation in Upcoming Investor and Industry Conferences
-
Zevra Therapeutics (ZVRA) Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million
-
Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million
-
Shoals Technologies Group, Inc. Announces Participation in Upcoming Events for the Investor Community
-
Snowflake Inc. (SNOW) PT Raised to $228 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on NVIDIA (NVDA)
-
GitLab Chief Financial Officer Brian Robins to Present at the 2025 Cantor Fitzgerald Global Technology Conference
-
Abzena Strengthens Executive Leadership Team with the Appointment of Taylor Boyd as CBO
-
DigitalOcean (DOCN) PT Raised to $43 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Harmony Biosciences Holdings Inc. (HRMY)
-
Xometry Inc (XMTR) PT Raised to $20 at Cantor Fitzgerald
-
Sprout Social Inc. (SPT) PT Lowered to $38 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on SoundThinking (SSTI)
-
Cantor Fitzgerald Reiterates Overweight Rating on Ultragenyx Pharma (RARE)
-
Cantor Fitzgerald Reiterates Neutral Rating on Supernus Pharmaceuticals (SUPN)
-
Cantor Fitzgerald Reiterates Overweight Rating on Instacart (CART)
-
Cantor Fitzgerald Reiterates Neutral Rating on Lucid Group Inc. (LCID)
-
MKS Instruments to Participate in Cantor Fitzgerald Global Technology Conference
-
CyberArk to Present at Upcoming Investor Conferences
-
Applied Materials to Participate in the Cantor Fitzgerald Global Technology Conference
-
Phoenix Group to Attend Cantor Fitzgerald Global Technology Conference In New York, USA
-
Lucid CEO steps down, company expects to more than double vehicle production this year
-
AxoGen, Inc. (AXGN) PT Raised to $24 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on SI-BONE Inc. (SIBN)
-
Riot Platforms (RIOT) PT Lowered to $21 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Neutral Rating on Zoom Video (ZM)
-
Ascendis Pharma (ASND) PT Raised to $200 at Cantor Fitzgerald
-
AIRO Group Holdings, Inc. Announces Filing of Registration Statement for a Proposed Initial Public Offering
-
Cantor Fitzgerald Starts Metsera Inc (MTSR) at Overweight
-
JFrog to Present at Upcoming Investor Conferences

